Something dramatic happened in the US healthcare market in 2015.
Something with implications for all healthcare stakeholders, including providers and institutions.
Specifically, the value of drug products was being quantified and put on display for the entire
Dealing with payers can be painful for providers!
You deliver healthcare services, and then have to fight tooth-and-nail for every dime you are owed.
Unfortunately, payers have created a complicated reimbursement system,
Recently, I attended an oncology medical conference that reminded me about the importance of understanding the role of drug pricing policy.
Needless to say, there was a lot of discussion about the high cost of
Drug companies are getting better at targeting patient value.
In 2010, a drug company was working on new ways to differentiate their cancer drug (Drug 2) from the market leader (Drug 1).
Both drugs had
Imagine receiving hundreds of new referrals.
Imagine growing your practice by 50% to 200% over just a few weeks.
Imagine helping thousands more patients each year.
These kind of results are not just possible, but they are highly likely.
But only for